540222:BOM
Laurus Labs Ltd
₹2,059.00
arrow_upward
+1.93%(+39.00) 1 日
10月16日, 15:59:49 GMT+5:30 · INR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_auto540222 の上位の分析情報を生成しています...
始値
₹2,027.35
高値
₹2,086.00
安値
₹2,027.35
時価総額
1.11兆
平均出来高
8.43万
取引量
10.31万
配当
0.10%
四半期配当
₹0.50
配当落ち日
2026/05/08
株価収益率
101.80
52 週高値
₹2,086.00
52 週安値
₹870.05
EPS
₹20.23
発行済株式数
1.06億
従業員数
7059
始値
₹2,027.35
高値
₹2,086.00
安値
₹2,027.35
時価総額
1.11兆
平均出来高
8.43万
取引量
10.31万
配当
0.10%
四半期配当
₹0.50
配当落ち日
2026/05/08
株価収益率
101.80
52 週高値
₹2,086.00
52 週安値
₹870.05
EPS
₹20.23
発行済株式数
1.06億
従業員数
7059
ニュース記事
情報源: ウェブソース、ニュース パートナー
The Economic Times
·
1 日前
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
プロフィール
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Laurus Labs Ltd について